- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Jul 15, 2024)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Jul 16, 2024 | T-1643-17 | CMC | Carry Telecom Inc. V. Ezphone Solution Ltd. Et.al. (Trade Mark) | Toronto | 1 h |
| Jul 16, 2024 | T-1105-22 | JR | Monster Energy Company V. Iicombined Co. Ltd. (Trade Mark - JR) | Ottawa | 2 d |
| Jul 16, 2024 | T-745-24 | CMC | Viiv Healthcare Company Et Al V. Sandoz Canada Inc. (Patent) | Toronto | 1 h |
| Jul 16, 2024 | T-959-23 | CMC | Portes Et Fenã?tres Verdun Ltã?e C. Nordik Cash And Carry Inc. (Trade Mark) | Montréal | 30 m |
| Jul 16, 2024 | T-923-24 | CMC | Janssen Inc. And Mitsubishi Tanabe Pharma Corporation V. Apotex Inc. (Patent) | Toronto | 30 m |
| Jul 16, 2024 | T-119-22 | CMC | Masontops, Inc. V. Northern Tool & Equipment Company, Inc. Et Al (Patent) | Toronto | 1 h |
| Jul 17, 2024 | T-1390-21 | M | Morinaga & Co., Ltd. V. Nhat Van Nguyen Et Al. (Trade Mark) | Toronto | 1 h |
| Jul 17, 2024 | T-1506-20 | CMC | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Ottawa | 30 m |
| Jul 18, 2024 | T-2751-23 | M | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Ottawa | 4 h |
| Jul 18, 2024 | T-652-24 | CMC | Otsuka Pharmaceutical Co., Ltd. V. Apotex Inc. (Patent) | Toronto | 1 h |
| Jul 18, 2024 | T-1583-24 | CMC | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | Toronto | 30 m |
| Jul 18, 2024 | T-1584-24 | CMC | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | Toronto | 30 m |
| Jul 18, 2024 | T-86-23 | TMC | Guardtek Systems Inc. Et Al. V. Guardteck Security Corp. Et Al. (unknown) | Ottawa | 1.5 h |
| Jul 18, 2024 | T-1690-22 | CMC | Fairview Ltd. V. The Registrar Of Trademarks (Trade Mark) | Toronto | 30 m |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Aug 12, 2024 | T-2133-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 10 d |
| Aug 12, 2024 | T-2139-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 10 d |
| Aug 19, 2024 | T-233-23 | Poseidon Llc. V. Canada (the Commissioner Of Patents) (unknown) | Toronto | 2 d |
| Aug 29, 2024 | T-2133-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Aug 29, 2024 | T-2139-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Sep 9, 2024 | T-435-22 | Australian Mud Company Pty Ltd Et Al. V. Boart Longyear Group Inc. Et Al. (Patent) | Toronto | 10 d |
| Sep 9, 2024 | T-754-22 | Sandvik Mining And Construction Oy And Sandvik Canada Inc. V. Epiroc Canada (Patent) | Toronto | 8 d |
| Sep 9, 2024 | T-1212-20 | Gillyboo Corporation V. Canadian Tire Corp. Ltd Et Al (Copyright) | Toronto | 5 d |
| Sep 16, 2024 | T-2582-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Pharmascience Inc. (Patent) | Montréal | 10 d |
| Sep 16, 2024 | T-86-23 | Guardtek Systems Inc. Et Al. V. Guardteck Security Corp. Et Al. (unknown) | Toronto | 10 d |
| Sep 19, 2024 | T-328-22 | Kerry Group Services International, Ltd. Et Al. V. Florida Food Products, Ll (Patent) | Toronto | 7 d |
| Sep 25, 2024 | T-754-22 | Sandvik Mining And Construction Oy And Sandvik Canada Inc. V. Epiroc Canada (Patent) | Toronto | 2 d |
| Oct 2, 2024 | T-2582-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Pharmascience Inc. (Patent) | Montréal | 2 d |
| Oct 15, 2024 | T-328-22 | Kerry Group Services International, Ltd. Et Al. V. Florida Food Products, Ll (Patent) | Toronto | 1 d |
| Oct 21, 2024 | T-1471-21 | Ge Renewable Energy Canada Inc V. Canmec Industrial Inc. Et Al. (Copyright) | Montréal | 10 d |
| Oct 28, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | Toronto | 16 d |
| Nov 12, 2024 | T-786-21 | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 10 d |
| Nov 12, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 10 d |
| Nov 25, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | Ottawa | 3 d |
| Nov 25, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 4 d |
| Dec 2, 2024 | T-786-21 | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 2 d |
| Dec 2, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 2 d |
| Dec 2, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | Toronto | 9 d |
| Dec 2, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 3 d |
| Dec 13, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 1 d |
| Dec 18, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | Toronto | 2 d |
| Jan 20, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 20, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 20, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 15 d |
| Jan 27, 2025 | T-1506-20 | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Winnipeg | 7 d |
| Feb 13, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 13, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 17, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 3 d |
| Mar 3, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 8 d |
| Mar 17, 2025 | T-1726-21 | 2660722 Ontario Inc. Et Al. V. Pacific Smoke International Inc. Et Al. (unknown) | Toronto | 10 d |
| Mar 20, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 1 d |
| Apr 28, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 21 d |
| Apr 28, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 15 d |
| Apr 28, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Apr 28, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 9 d |
| May 12, 2025 | T-1775-23 | Amgen Canada Inc.et Al. V. Natco Pharma (canada) Inc. (Patent) | To be determined (TrialJA) | 19 d |
| May 12, 2025 | T-1777-23 | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | To be determined (TrialJA) | 19 d |
| May 15, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| May 15, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 1 d |
| May 21, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 3 d |
| May 26, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 10 d |
| May 26, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 10 d |
| Jun 2, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 3 d |
| Jun 11, 2025 | T-1775-23 | Amgen Canada Inc.et Al. V. Natco Pharma (canada) Inc. (Patent) | To be determined (TrialJA) | 2 d |
| Jun 11, 2025 | T-1777-23 | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | To be determined (TrialJA) | 2 d |
| Jun 11, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 2 d |
| Jun 12, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 1 d |
| Jun 23, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 14 d |
| Jul 16, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 2 d |
| Jul 22, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Jul 22, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Aug 11, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 8 d |
| Aug 18, 2025 | T-1917-23 | Bayer Inc And Regeneron Pharmaceuticals, Inc V. Amgen Canada Inc (Patent) | Toronto | 10 d |
| Aug 18, 2025 | T-1918-23 | Bayer Inc Et Al., V. Amgen Canada Inc (Patent) | Toronto | 10 d |
| Aug 18, 2025 | T-1919-23 | Bayer Inc Et Al., V. Amgen Canada Inc (Patent) | Toronto | 10 d |
| Aug 25, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-2751-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Toronto | 12 d |
| Sep 2, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Sep 2, 2025 | T-1917-23 | Bayer Inc And Regeneron Pharmaceuticals, Inc V. Amgen Canada Inc (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-1918-23 | Bayer Inc Et Al., V. Amgen Canada Inc (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-1919-23 | Bayer Inc Et Al., V. Amgen Canada Inc (Patent) | Toronto | 2 d |
| Sep 15, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| Sep 22, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 22, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 25, 2025 | T-2751-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Ottawa | 2 d |
| Oct 6, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 6, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 27, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Nov 12, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 2 d |
| Nov 12, 2025 | T-296-24 | Bayer Inc. Et Al. V. Natco Pharma (canada) Inc. Et Al. (Patent) | Ottawa | 11 d |
| Nov 12, 2025 | T-1779-23 | Samsung Bioepis Co., Ltd V. Alexion Pharmaceuticals, Inc. (Copyright) | Toronto | 28 d |
| Nov 12, 2025 | T-1584-23 | Amgen Canada Inc. V. Alexion Pharmaceuticals, Inc. (Patent) | Toronto | 28 d |
| Nov 17, 2025 | T-2148-23 | Outsuka Pharmaceutical Co. Ltd. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Nov 24, 2025 | T-91-20 | University Of Saskatchewan Et Al. V. Newagco Inc. Et Al. (Patent) | Toronto | 8 d |
| Nov 27, 2025 | T-297-23 | Dermaspark Products Inc. Et Al. V. Natural Oasis Day Spa Ltd. Et Al (Trade Mark) | Ottawa | 12 d |
| Dec 1, 2025 | T-675-24 | Pfizer Canada Ulc Et Al. V. Glenmark Pharmaceuticals Canada Inc. Et Al. (Patent) | To be determined (TrialJA) | 10 d |
| Dec 8, 2025 | T-91-20 | University Of Saskatchewan Et Al. V. Newagco Inc. Et Al. (Patent) | Toronto | 2 d |
| Jan 19, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 10 d |
| Feb 5, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 2 d |
| Mar 16, 2026 | T-1321-24 | Lundbeck Canada Inc. Et Al. V. Jamp Pharma Corporation (Patent - Vortioxetine*) | To be determined (TrialJA) | 8 d |
| Mar 30, 2026 | T-1321-24 | Lundbeck Canada Inc. Et Al. V. Jamp Pharma Corporation (Patent - Vortioxetine*) | To be determined (TrialJA) | 2 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Jul 16, 2024 | T-1105-22 | Monster Energy Company V. Iicombined Co. Ltd. | Trade Mark Opposition | Ottawa | 2 d |
| Jul 23, 2024 | T-1706-23 | 2k4 Inc. O/a Indican Pictures V. Indiecan Entertainment Inc. | Trade Mark - Passing Off | Ottawa | 1 d |
| Aug 28, 2024 | T-2702-23 | Meridianâ creditâ unionâ limited V. Connect First And Servusâ creditâ unionâ ltd. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Dec 2, 2024 | T-340-22 | Vermillion Networks Inc. V. Cenovus Energy Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 5 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.